THOUSAND
OAKS, Calif., Feb. 28,
2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will
present at the 45th Annual TD Cowen Health Care
Conference at 9:10 a.m. ET on
Wednesday, March 5, 2025. Jay
Bradner, executive vice president of Research and
Development at Amgen, will participate in a fireside chat at the
conference. The webcast will be broadcast over the internet
simultaneously and will be available to members of the news media,
investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation
times, webcast availability and webcast links are noted on Amgen's
Investor Relations Events Calendar. The webcast will be archived
and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers
innovative medicines to help millions of patients in their fight
against some of the world's toughest diseases. More than 40 years
ago, Amgen helped to establish the biotechnology industry
and remains on the cutting-edge of innovation, using technology and
human genetic data to push beyond what's known
today. Amgen is advancing a broad and deep pipeline that
builds on its existing portfolio of medicines to treat cancer,
heart disease, osteoporosis, inflammatory diseases and rare
diseases.
In 2024, Amgen was named one of the "World's Most
Innovative Companies" by Fast Company and one of
"America's Best Large Employers" by Forbes, among
other external recognitions. Amgen is one of the 30
companies that comprise the Dow Jones Industrial Average®, and it
is also part of the Nasdaq-100 Index®, which includes the largest
and most innovative non-financial companies listed on
the Nasdaq Stock Market based on market
capitalization.
For more information, visit Amgen.com and follow us on
X (formerly known as Twitter), LinkedIn,
Instagram, YouTube and Threads.
CONTACT: Amgen, Thousand
Oaks
Elissa Snook, 609-251-1407
(media)
Justin Claeys, 805-313-9775
(investors)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-45th-annual-td-cowen-health-care-conference-302388840.html
SOURCE Amgen
